Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

07. April 2022 16:05 ET | Quelle: Seer, Inc.

Seer to Report First Quarter Financial Results on May 4, 2022

REDWOOD CITY, Calif., April 07, 2022 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report...
16. März 2022 16:05 ET | Quelle: Seer, Inc.

Seer Announces Appointment of Scott D. Thomas as Chief Commercial Officer

REDWOOD CITY, Calif., March 16, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, announced today the appointment...
14. März 2022 08:00 ET | Quelle: Seer, Inc.

Seer Announces Publication of Seminal Study Demonstrating Superior Performance of Technology Platform for Deep, Unbiased, Precise, Scalable Proteomics in the Proceedings of the National Academy of Sciences

Published results highlight simultaneous superior performance across depth, precision, and throughput versus conventional plasma proteomics workflows REDWOOD CITY, Calif., March 14, 2022 (GLOBE...
28. Februar 2022 16:05 ET | Quelle: Seer, Inc.

Seer Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Full Year 2022 Outlook

REDWOOD CITY, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results...
22. Februar 2022 16:05 ET | Quelle: Seer, Inc.

Seer to Present at the Cowen 42nd Annual Health Care Conference

REDWOOD CITY, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company...
01. Februar 2022 16:05 ET | Quelle: Seer, Inc.

Seer to Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2021

REDWOOD CITY, Calif., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report...
10. Januar 2022 14:58 ET | Quelle: Seer, Inc.

Updated: Seer Announces Broad Commercial Release of the Proteograph™ Product Suite and Launches Centers of Excellence Program

REDWOOD CITY, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced Broad Commercial...
10. Januar 2022 09:00 ET | Quelle: Seer, Inc.

Seer, Discovery Life Sciences and SCIEX Announce First-Of-Its-Kind Proteogenomics Consortium for Large-Scale Studies

REDWOOD CITY, Calif. and HUNTSVILLE, Ala. and FRAMINGHAM, Mass., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for...
10. Januar 2022 08:00 ET | Quelle: Seer, Inc.

Seer Announces Broad Commercial Release of the Proteograph™ Product Suite and Launches Centers of Excellence Program

REDWOOD CITY, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced Broad Commercial...
29. Dezember 2021 08:05 ET | Quelle: Seer, Inc.

Seer to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference

REDWOOD CITY, Calif., Dec. 29, 2021 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company...

Vorherige Seite

Nächste Seite